Global Pharma ADMET Testing Market Size and Forecast 2024-2033|Thermo Fisher Scientific Inc., Abbott Laboratories, The Merck Group, Laboratory Corporation of America Holdings, IQVIA Inc

The Pharma ADMET Testing Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Pharma ADMET Testing Market:

https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report

According to The Business Research Company’s Pharma ADMET Testing Global Market Report 2024, The pharma admet testing market size has grown rapidly in recent years. It will grow from $8.62 billion in 2023 to $9.61 billion in 2024 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to growth in biopharmaceuticals and biosimilars, rise in drug development activities, growing awareness of drug safety, globalization of clinical trials, shift towards in silico modeling

The pharma admet testing market size is expected to see rapid growth in the next few years. It will grow to $14.87 billion in 2028 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to environmental toxicology and safety assessment, awareness of pharmacogenomics, focus on precision medicine, growth of biologics and biosimilars, integration of artificial intelligence (ai), expanded regulatory requirements, rise in orphan drug development. Major trends in the forecast period include increasing collaboration in research, rapid technological innovations, advancements in analytical technologies, continuous monitoring of drug safety, environmental impact considerations

The rising number of product approvals is driving the pharma ADMET testing market. Product approvals refer to the process by which regulatory authorities, such as the Food and Drug Administration (FDA) in the United States or the European Medicines Agency (EMA) in Europe, grant permission for a product to be marketed and sold to the public. ADMET testing is beneficial for determining the safety and efficacy of novel products and is mandatory in product regulatory approvals. For instance, in January 2022, according to the Center for Drug Evaluation and Research, a US-based Government agency, in 2020, 53 drugs were approved, up from 48 drugs approved in 2019. Therefore, the rising number of product approvals drives the pharma ADMET testing market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=12024&type=smp

The pharma admet testing market covered in this report is segmented –

1) By Testing Type: In Vivo ADMET Testing, In Vitro ADMET Testing, In Silico ADMET Testing

2) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology

3) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications

Product innovations are a key trend gaining popularity in the pharma ADMET testing market. Major companies in the pharma ADMET testing market are introducing innovative products such as Logica to sustain their position in the market. For instance, in April 2022, Charles River Laboratories International Inc., a US-based pharmaceutical company, and Valo Health Inc., a US-based AI-health solution company, launched Logica, an AI-based drug development solution. The new solution leverages Valo’s AI-powered Opal Computational Platform to provide users with ADMET testing services and other drug delivery solutions. Logi¬ca makes use of industry-leading predictive models, chem¬i¬cal design and syn¬the¬sis capabil¬i-ties, DNA-encod¬ed libraries, and in sil¬i¬co high through¬put screen¬ing from Valo’s Opal Com¬pu¬ta¬tion¬al Plat-form, in addition to the Charles River’s lead¬ing capa¬bil¬i¬ties in all aspects of dis¬cov¬ery opti¬miza¬tion includ¬ing high through¬put screen¬ing, med¬i¬c¬i¬nal chem¬istry, ADME, biol¬o¬gy, phar¬ma¬col¬o¬gy, and ulti¬mate¬ly safe¬ty test-ing and IND sub¬mis¬sion.

The pharma admet testing market report table of contents includes:

1. Executive Summary

2. Pharma ADMET Testing Market Characteristics

3. Pharma ADMET Testing Market Trends And Strategies

4. Pharma ADMET Testing Market – Macro Economic Scenario

5. Global Pharma ADMET Testing Market Size and Growth

26. South America Pharma ADMET Testing Market

27. Brazil Pharma ADMET Testing Market

28. Middle East Pharma ADMET Testing Market

29. Africa Pharma ADMET Testing Market

30. Pharma ADMET Testing Market Competitive Landscape And Company Profiles

Top Major Players: